Felix J. Baker

Dr. Baker is Co-founder and Managing Member of Baker Bros. Advisors LP, a biotechnology-focused investment adviser to fund partnerships whose investors are primarily endowments and foundations. He also serves on the Board of Directors of Seagen, Kodiak Sciences, and Kiniksa Pharmaceuticals and served on the Board of Alexion Pharmaceuticals until its acquisition by AstraZeneca in 2021. Dr. Baker holds a B.S. and a Ph.D. in Immunology from Stanford University, where he also completed two years of medical school.